Your browser doesn't support javascript.
loading
Impact of Initial Imaging Protocol on Likelihood of Endovascular Stroke Therapy.
Lopez-Rivera, Victor; Abdelkhaleq, Rania; Yamal, Jose-Miguel; Singh, Noopur; Savitz, Sean I; Czap, Alexandra L; Alderazi, Yazan; Chen, Peng R; Grotta, James C; Blackburn, Spiros; Spiegel, Gary; Dannenbaum, Mark J; Wu, Tzu-Ching; Yoo, Albert J; McCullough, Louise D; Sheth, Sunil A.
Afiliação
  • Lopez-Rivera V; Department of Neurology (V.L.-R., R.A., S.I.S., A.L.C., Y.A., G.S., T.-C.W., L.D.M., S.A.S.).
  • Abdelkhaleq R; Department of Neurology (V.L.-R., R.A., S.I.S., A.L.C., Y.A., G.S., T.-C.W., L.D.M., S.A.S.).
  • Yamal JM; School of Public Health (J.-M.Y., N.S.), UTHealth, Houston, TX.
  • Singh N; Institute for Stroke and Cerebrovascular Disease (J.-M.Y., S.I.S., A.L.C., Y.A., P.R.C., J.C.G., S.B., S.A.S.), UTHealth, Houston, TX.
  • Savitz SI; School of Public Health (J.-M.Y., N.S.), UTHealth, Houston, TX.
  • Czap AL; Department of Neurology (V.L.-R., R.A., S.I.S., A.L.C., Y.A., G.S., T.-C.W., L.D.M., S.A.S.).
  • Alderazi Y; Institute for Stroke and Cerebrovascular Disease (J.-M.Y., S.I.S., A.L.C., Y.A., P.R.C., J.C.G., S.B., S.A.S.), UTHealth, Houston, TX.
  • Chen PR; Department of Neurology (V.L.-R., R.A., S.I.S., A.L.C., Y.A., G.S., T.-C.W., L.D.M., S.A.S.).
  • Grotta JC; Institute for Stroke and Cerebrovascular Disease (J.-M.Y., S.I.S., A.L.C., Y.A., P.R.C., J.C.G., S.B., S.A.S.), UTHealth, Houston, TX.
  • Blackburn S; Institute for Stroke and Cerebrovascular Disease (J.-M.Y., S.I.S., A.L.C., Y.A., P.R.C., J.C.G., S.B., S.A.S.), UTHealth, Houston, TX.
  • Spiegel G; Department of Neurosurgery of McGovern Medical School (P.R.C., S.B., M.J.D.), UTHealth, Houston, TX.
  • Dannenbaum MJ; Institute for Stroke and Cerebrovascular Disease (J.-M.Y., S.I.S., A.L.C., Y.A., P.R.C., J.C.G., S.B., S.A.S.), UTHealth, Houston, TX.
  • Wu TC; Institute for Stroke and Cerebrovascular Disease (J.-M.Y., S.I.S., A.L.C., Y.A., P.R.C., J.C.G., S.B., S.A.S.), UTHealth, Houston, TX.
  • Yoo AJ; Clinical Innovation and Research Institute, Memorial Hermann Hospital, Texas Medical Center, Houston (J.C.G.).
  • McCullough LD; Department of Neurosurgery of McGovern Medical School (P.R.C., S.B., M.J.D.), UTHealth, Houston, TX.
  • Sheth SA; Institute for Stroke and Cerebrovascular Disease (J.-M.Y., S.I.S., A.L.C., Y.A., P.R.C., J.C.G., S.B., S.A.S.), UTHealth, Houston, TX.
Stroke ; 51(10): 3055-3063, 2020 10.
Article em En | MEDLINE | ID: mdl-32878563
ABSTRACT
BACKGROUND AND

PURPOSE:

Noncontrast head CT and CT perfusion (CTP) are both used to screen for endovascular stroke therapy (EST), but the impact of imaging strategy on likelihood of EST is undetermined. Here, we examine the influence of CTP utilization on likelihood of EST in patients with large vessel occlusion (LVO).

METHODS:

We identified patients with acute ischemic stroke at 4 comprehensive stroke centers. All 4 hospitals had 24/7 CTP and EST capability and were covered by a single physician group (Neurology, NeuroIntervention, NeuroICU). All centers performed noncontrast head CT and CT angiography in the initial evaluation. One center also performed CTP routinely with high CTP utilization (CTP-H), and the others performed CTP optionally with lower utilization (CTP-L). Primary outcome was likelihood of EST. Multivariable logistic regression was used to determine whether facility type (CTP-H versus CTP-L) was associated with EST adjusting for age, prestroke mRS, National Institutes of Health Stroke Scale, Alberta Stroke Program Early CT Score, LVO location, time window, and intravenous tPA (tissue-type plasminogen activator).

RESULTS:

Among 3107 patients with acute ischemic stroke, 715 had LVO, of which 403 (56%) presented to CTP-H and 312 (44%) presented to CTP-L. CTP utilization among LVO patients was greater at CTP-H centers (72% versus 18%, CTP-H versus CTP-L, P<0.01). In univariable analysis, EST rates for patients with LVO were similar between CTP-H versus CTP-L (46% versus 49%). In multivariable analysis, patients with LVO were less likely to undergo EST at CTP-H (odds ratio, 0.59 [0.41-0.85]). This finding was maintained in multiple patient subsets including late time window, anterior circulation LVO, and direct presentation patients. Ninety-day functional independence (odds ratio, 1.04 [0.70-1.54]) was not different, nor were rates of post-EST PH-2 hemorrhage (1% versus 1%).

CONCLUSIONS:

We identified an increased likelihood for undergoing EST in centers with lower CTP utilization, which was not associated with worse clinical outcomes or increased hemorrhage. These findings suggest under-treatment bias with routine CTP.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Encéfalo / Isquemia Encefálica / Ativador de Plasminogênio Tecidual / Acidente Vascular Cerebral / Fibrinolíticos Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Encéfalo / Isquemia Encefálica / Ativador de Plasminogênio Tecidual / Acidente Vascular Cerebral / Fibrinolíticos Idioma: En Ano de publicação: 2020 Tipo de documento: Article